Home LiteratureArticle Details
PMID: 12789291 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Death receptors and melanoma resistance to apoptosis.

Oncogene ·Vol. 22 ·No. 20 ·2003-05-19 ·Pages 3152-61

Ivanov VN, Bhoumik A, Ronai Z

Abstract

Impaired ability to undergo programmed cell death in response to a wide range of external stimuli acquires melanomas a selective advantage for progression and metastasis as well as their notorious resistance to therapy. Better understanding of mechanisms that govern apoptosis has enabled identification of diverse routes by which melanomas manage to escape stimuli of apoptosis. Changes at genomic, transcriptional and post-translational levels of G-proteins and protein kinases (Ras, B-Raf) and their transcription factor effectors (c-Jun, ATF2, Stat3 and NF-kappaB) affects TNF, Fas and TRAIL receptors, which play important roles in acquiring melanoma's resistance to apoptosis. Here, we summarize our current understanding of changes that alters the regulation of death receptors during melanoma development.

MeSH Terms
Activating Transcription Factor 2 Animals Antigens, CD/genetics,metabolism Apoptosis/drug effects,physiology Apoptosis Regulatory Proteins CASP8 and FADD-Like Apoptosis Regulating Protein Carrier Proteins/genetics,metabolism Cyclic AMP Response Element-Binding Protein/antagonists & inhibitors,metabolism Drug Resistance, Neoplasm/physiology Humans Intracellular Signaling Peptides and Proteins Melanoma/drug therapy,metabolism,pathology Membrane Glycoproteins/metabolism NF-kappa B/drug effects,metabolism Proto-Oncogene Proteins c-jun/genetics,metabolism Receptors, TNF-Related Apoptosis-Inducing Ligand Receptors, Tumor Necrosis Factor/genetics,metabolism Receptors, Tumor Necrosis Factor, Type I Signal Transduction TNF-Related Apoptosis-Inducing Ligand Transcription Factors/antagonists & inhibitors,drug effects,genetics,metabolism Tumor Necrosis Factor-alpha/metabolism Tumor Suppressor Protein p53/genetics,metabolism fas Receptor/drug effects,metabolism
Chemicals
ATF2 protein, human Activating Transcription Factor 2 Antigens, CD Apoptosis Regulatory Proteins CASP8 and FADD-Like Apoptosis Regulating Protein CFLAR protein, human Carrier Proteins Cyclic AMP Response Element-Binding Protein Intracellular Signaling Peptides and Proteins Membrane Glycoproteins NF-kappa B Proto-Oncogene Proteins c-jun Receptors, TNF-Related Apoptosis-Inducing Ligand Receptors, Tumor Necrosis Factor Receptors, Tumor Necrosis Factor, Type I TNF-Related Apoptosis-Inducing Ligand TNFRSF10A protein, human TNFSF10 protein, human Transcription Factors Tumor Necrosis Factor-alpha Tumor Suppressor Protein p53 fas Receptor
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Ivanov Vladimir N
Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, NY 10029, USA.
Bhoumik Anindita
Ronai Ze'ev
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
0950-9232
Published
2003-05-19
Pages
3152-61
Language
English
Region
England
NLM ID
8711562
Subset
IM
Grants
NCI NIH HHS · CA559908 · United States
NCI NIH HHS · CA55995 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com